Rocket Doctor AI Inc. (AIRDF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Rocket Doctor AI Inc. (AIRDF) with AI Score 56/100 (Hold). Rocket Doctor AI Inc. provides personalized healthcare information services in Canada, utilizing a mobile application for symptom assessment and ongoing wellness management. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 17, 2026Rocket Doctor AI Inc. (AIRDF) Healthcare & Pipeline Overview
Rocket Doctor AI Inc., based in Canada, develops and offers a mobile application for personalized healthcare information and symptom assessment. The company provides digital health solutions and medical education resources, positioning itself within the competitive healthcare information services sector with a focus on mobile accessibility and user-centric design.
Investment Thesis
Rocket Doctor AI Inc. presents an investment opportunity within the growing digital health information services sector. The company's focus on personalized healthcare through its mobile application and digital health tools aligns with the increasing demand for accessible and convenient healthcare solutions. With a market capitalization of $0.04 billion and a negative P/E ratio of -4.44, the company is currently operating at a loss, indicated by a profit margin of -1670.1%. However, the company's high gross margin of 89.4% suggests potential for profitability as it scales its operations. Key growth catalysts include expanding the user base of its mobile application and developing new digital health solutions. Investors should monitor the company's ability to achieve profitability and manage its operational costs effectively. The company's beta of -0.32 indicates low volatility compared to the market.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $0.04 billion indicates a small-cap company with potential for growth.
- Negative P/E ratio of -4.44 reflects current losses, but also potential for future earnings growth.
- Gross margin of 89.4% demonstrates strong pricing power and efficient cost management.
- Profit margin of -1670.1% highlights significant operational losses requiring strategic improvement.
- Beta of -0.32 suggests the stock is less volatile than the overall market.
Competitors & Peers
Strengths
- Proprietary mobile application for symptom assessment.
- Focus on personalized healthcare information.
- Partnerships with healthcare providers.
- High gross margin of 89.4%.
Weaknesses
- Negative P/E ratio and profit margin indicate current losses.
- Limited geographic presence in Canada.
- Small market capitalization of $0.04 billion.
- Reliance on mobile application for revenue generation.
Catalysts
- Upcoming: Expansion of mobile application user base through targeted marketing campaigns.
- Ongoing: Development of new digital health solutions to address unmet needs in the market.
- Ongoing: Partnerships with healthcare providers to integrate its solutions into their existing workflows.
- Upcoming: Geographic expansion to other countries with similar healthcare needs.
- Ongoing: Integration of AI and machine learning into its platform to enhance its capabilities.
Risks
- Potential: Competition from established healthcare information service providers with greater resources.
- Potential: Regulatory changes in the healthcare industry that could impact the company's operations.
- Ongoing: Data privacy and security concerns related to the collection and storage of patient data.
- Potential: Technological obsolescence due to rapid advancements in digital health technologies.
- Ongoing: Limited financial disclosure and liquidity associated with trading on the OTC Other tier.
Growth Opportunities
- Expansion of Mobile Application User Base: Rocket Doctor AI Inc. can grow by expanding the user base of its mobile application. The global mobile health market is projected to reach $332.5 billion by 2028, growing at a CAGR of 17.9%. By focusing on user acquisition through targeted marketing and partnerships with healthcare providers, Rocket Doctor AI Inc. can increase its market share and revenue. Timeline: Ongoing.
- Development of New Digital Health Solutions: The company can develop new digital health solutions to address unmet needs in the market. The digital health market is expected to reach $660 billion by 2027. By investing in research and development, Rocket Doctor AI Inc. can create innovative products and services that attract new customers and generate additional revenue streams. Timeline: Ongoing.
- Partnerships with Healthcare Providers: Rocket Doctor AI Inc. can partner with healthcare providers to integrate its solutions into their existing workflows. The healthcare IT market is projected to reach $390.7 billion by 2027. By collaborating with hospitals, clinics, and other healthcare organizations, Rocket Doctor AI Inc. can expand its reach and improve patient outcomes. Timeline: Ongoing.
- Geographic Expansion: The company can expand its operations beyond Canada to other countries with similar healthcare needs. The global healthcare market is projected to reach $10 trillion by 2022. By entering new markets, Rocket Doctor AI Inc. can diversify its revenue streams and reduce its reliance on the Canadian market. Timeline: Within the next 3-5 years.
- Integration of AI and Machine Learning: Rocket Doctor AI Inc. can further integrate AI and machine learning into its platform to enhance its capabilities. The AI in healthcare market is projected to reach $45.2 billion by 2026. By leveraging AI, the company can improve the accuracy of its symptom assessments, personalize its recommendations, and automate its processes. Timeline: Ongoing.
Opportunities
- Expansion of mobile application user base.
- Development of new digital health solutions.
- Geographic expansion to other countries.
- Integration of AI and machine learning.
Threats
- Competition from established healthcare information service providers.
- Regulatory changes in the healthcare industry.
- Data privacy and security concerns.
- Technological obsolescence.
Competitive Advantages
- Proprietary AI-driven symptom assessment technology.
- Established partnerships with healthcare providers.
- First-mover advantage in the Canadian market for personalized healthcare information services.
About AIRDF
Rocket Doctor AI Inc., formerly known as Treatment.com AI Inc., was incorporated in 2018 and is headquartered in Vancouver, Canada. The company focuses on delivering personalized healthcare information services through its mobile application. This application allows users to assess their symptoms, address health concerns, and manage their wellness. The company also offers a digital health app that provides insights into health management. Rocket Doctor AI Inc. provides medical education, medical clinic, and clinical advisor solutions, enhancing its service offerings. The company aims to provide accessible and personalized healthcare information resources to its users. The company rebranded in August 2025 to reflect its focus on AI-driven healthcare solutions. Rocket Doctor AI Inc. operates primarily in Canada, focusing on expanding its digital health services and mobile application reach within the region. The company's business model centers around providing accessible and personalized healthcare information through digital platforms.
What They Do
- Develops a mobile application for symptom assessment.
- Offers personalized healthcare information services.
- Provides a digital health app for health insights.
- Offers medical education solutions.
- Provides medical clinic solutions.
- Provides clinical advisor solutions.
- Offers healthcare information resources.
Business Model
- Generates revenue through subscriptions to its digital health app.
- Partnerships with healthcare providers for integration of its solutions.
- Offers medical education and clinical advisor solutions on a fee-for-service basis.
Industry Context
Rocket Doctor AI Inc. operates in the healthcare information services sector, which is experiencing significant growth due to increasing demand for digital health solutions and personalized healthcare. The market is competitive, with players like BLOZF (BioLife Sciences Inc.), CRRVF (CareRx Corporation), DSOL (Data Solutions Holdings, Inc.), HBPCF (HBP Corp), and INNMF (InnoMedica Holdings AG). These companies offer various digital health services, including telehealth, remote patient monitoring, and healthcare data analytics. Rocket Doctor AI Inc. differentiates itself through its focus on AI-driven symptom assessment and personalized healthcare information delivered via its mobile application. The industry is driven by technological advancements, regulatory changes, and increasing healthcare costs, creating opportunities for innovative companies like Rocket Doctor AI Inc.
Key Customers
- Individual users seeking personalized healthcare information.
- Healthcare providers looking to integrate digital health solutions.
- Medical professionals seeking medical education resources.
Financials
Chart & Info
Rocket Doctor AI Inc. (AIRDF) stock price: Price data unavailable
Latest News
-
Rocket Doctor Expands California Coverage with New In-Network Agreement with a National Insurer, Adding Over 2 Million Members
globenewswire.com · Mar 24, 2026
-
Rocket Doctor AI Announces $2.049 Million Gross Proceeds from Warrant Exercises
Yahoo! Finance: AIRDF News · Mar 17, 2026
-
Rocket Doctor Strengthens New York Footprint with Additional In-Network Medicare Advantage Agreement
Yahoo! Finance: AIRDF News · Mar 10, 2026
-
Rocket Doctor AI Signs New Contract With "Major" U.S. Insurer
Yahoo! Finance: AIRDF News · Mar 3, 2026
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AIRDF.
Price Targets
Wall Street price target analysis for AIRDF.
MoonshotScore
What does this score mean?
The MoonshotScore rates AIRDF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
Rocket Doctor Expands California Coverage with New In-Network Agreement with a National Insurer, Adding Over 2 Million Members
Rocket Doctor AI Announces $2.049 Million Gross Proceeds from Warrant Exercises
Rocket Doctor Strengthens New York Footprint with Additional In-Network Medicare Advantage Agreement
Rocket Doctor AI Signs New Contract With "Major" U.S. Insurer
Leadership: Essam Hamza
CEO
Essam Hamza is the CEO of Rocket Doctor AI Inc. His background includes experience in healthcare technology and business development. He has a track record of leading technology companies and driving innovation in the healthcare sector. His expertise lies in developing and implementing digital health solutions that improve patient outcomes and reduce healthcare costs. He is committed to expanding Rocket Doctor AI Inc.'s reach and impact in the healthcare industry.
Track Record: Under Essam Hamza's leadership, Rocket Doctor AI Inc. has focused on developing its mobile application and expanding its partnerships with healthcare providers. He has overseen the company's rebranding efforts and its transition to an AI-driven healthcare solutions provider. His strategic decisions have positioned the company for growth in the digital health market.
AIRDF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Rocket Doctor AI Inc. may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risk due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases the risk of investing in AIRDF.
- Lower liquidity can make it difficult to buy or sell shares at desired prices.
- Lack of regulatory oversight compared to major exchanges.
- Potential for price manipulation and fraud.
- Higher volatility due to limited trading activity.
- Verify the company's financial statements and disclosures.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance.
- Monitor the company's trading volume and price volatility.
- Consult with a financial advisor before investing.
- Understand the risks associated with investing in OTC stocks.
- Company's focus on AI-driven healthcare solutions.
- Partnerships with healthcare providers.
- Development of a mobile application for symptom assessment.
- Presence of a CEO with experience in healthcare technology.
- Company's headquarters in Vancouver, Canada.
AIRDF Healthcare Stock FAQ
What does Rocket Doctor AI Inc. do?
Rocket Doctor AI Inc. is a Canadian company that provides personalized healthcare information services. It develops and offers a mobile application that allows users to assess their symptoms, address health concerns, and manage their wellness. The company also provides a digital health app for health insights, as well as medical education, medical clinic, and clinical advisor solutions. Rocket Doctor AI Inc. aims to provide accessible and personalized healthcare information resources through digital platforms, focusing on AI-driven symptom assessment and healthcare solutions.
What do analysts say about AIRDF stock?
As of March 17, 2026, there is no available analyst coverage or consensus for Rocket Doctor AI Inc. (AIRDF) due to its OTC listing and small market capitalization. Key valuation metrics such as P/E ratio (-4.44) and profit margin (-1670.1%) indicate the company is currently unprofitable, while its gross margin of 89.4% suggests potential for future profitability. Investors should conduct their own due diligence and assess the company's growth prospects and risk factors before making any investment decisions.
What are the main risks for AIRDF?
The main risks for Rocket Doctor AI Inc. include competition from established healthcare information service providers, regulatory changes in the healthcare industry, and data privacy and security concerns. Additionally, the company faces the risk of technological obsolescence due to rapid advancements in digital health technologies. As an OTC-listed company, AIRDF also carries risks associated with limited financial disclosure, lower liquidity, and potential for price volatility. Investors should carefully consider these risks before investing in AIRDF.
What are the key factors to evaluate for AIRDF?
Rocket Doctor AI Inc. (AIRDF) currently holds an AI score of 56/100, indicating moderate score. Key strength: Proprietary mobile application for symptom assessment.. Primary risk to monitor: Potential: Competition from established healthcare information service providers with greater resources.. This is not financial advice.
How frequently does AIRDF data refresh on this page?
AIRDF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven AIRDF's recent stock price performance?
Recent price movement in Rocket Doctor AI Inc. (AIRDF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Proprietary mobile application for symptom assessment.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider AIRDF overvalued or undervalued right now?
Determining whether Rocket Doctor AI Inc. (AIRDF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying AIRDF?
Before investing in Rocket Doctor AI Inc. (AIRDF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- OTC analysis is based on general knowledge of OTC markets and may not reflect specific details of AIRDF.
- AI insight is pending and not included in this analysis.